Page last updated: 2024-08-26

yttrium radioisotopes and Hodgkin Disease

yttrium radioisotopes has been researched along with Hodgkin Disease in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (10.00)	18.7374
1990's	9 (45.00)	18.2507
2000's	5 (25.00)	29.6817
2010's	3 (15.00)	24.3611
2020's	1 (5.00)	2.80

Authors

Authors	Studies
Adhikarla, V; Bading, J; Cao, T; Chen, R; Colcher, D; Dandapani, S; Forman, SJ; Herrera, AF; Karras, N; McTague, P; Mei, M; Nademanee, A; Palmer, J; Poku, EK; Popplewell, L; Sahebi, F; Shively, JE; Simpson, J; Smith, DL; Smith, E; Song, J; Spielberger, R; Thomas, SH; Tsai, NC; Wong, J; Wu, AM; Yamauchi, D; Yazaki, P	1
Bron, D; de Wind, A; Golstein, SC; Muylle, K; Spilleboudt, C; Vercruyssen, M	1
Bonner, WM; Brechbiel, MW; Brown, M; Bryant, BR; Carrasquillo, JA; Chen, C; Conlon, KC; Corcoran, E; Fioravanti, S; Fleisher, TA; Goldman, CK; Jaffe, ES; Janik, JE; Junghans, RP; Lee, CC; Lee, JH; Morris, JC; O'Mahony, D; Paik, CH; Pittaluga, S; Redon, CE; Stewart, DM; Waldmann, TA; Whatley, M; White, JD; Worthy, T	1
Neelapu, SS; Sharma, P	1
Wong, F; Younes, A	1
Decaudin, D; Djeridane, M; Kadouche, J; Levy, R; Lokiec, F; Morschhauser, F; Pecking, A	1
Borchmann, P; Dietlein, M; Engert, A; Hallek, M; Kobe, C; Schicha, H; Schnell, R; Schomäcker, K	1
Morton, JD; Quadri, SM; Vriesendorp, HM	1
Baranowska-Kortylewicz, J; Dalrymple, GV; Harrison, KA; Quadri, SM	1
Herpst, JM; Klein, JL; Leichner, PK; Quadri, SM; Vriesendorp, HM	1
Abrams, RA; Armitage, JO; Bierman, PJ; Dicke, KA; Klein, JL; Leichner, PK; Quadri, SM; Vose, JM; Vriesendorp, HM	1
Cromeens, DM; Freedman, RS; Jaeckle, KA; Quadri, SM; Vriesendorp, HM	1
Andersson, BS; Dicke, KA; Quadri, SM; Vriesendorp, HM; Wyllie, CT	1
Askew, E; Borchardt, PE; Harris, L; Lai, J; Quadri, SM; Schweichel, L; Vriesendorp, HM; Wucher, R	1
Gans, S; Kramer, G; Leer, J; Rijnders, A	1
Quadri, SM; Vriesendorp, HM	1
Klein, JL; Leichner, PK; Onyekwere, OC; Quadri, SM; Shao, Y; Stinson, RL; Vriesendorp, HM; Williams, JR	1
Germack, MA; Herpst, JM; Klein, JL; Leichner, PK; Loudenslager, DM; Order, SE; Vriesendorp, HM	1
Herpst, JM; Klein, JL; Leichner, PK; Order, SE; Vriesendorp, HM	1
Order, SE	1

Reviews

2 review(s) available for yttrium radioisotopes and Hodgkin Disease

Article	Year
Review of five consecutive studies of radiolabeled immunoglobulin therapy in Hodgkin's disease. Cancer research, 1995, Dec-01, Volume: 55, Issue:23 Suppl Topics: Animals; Clinical Trials as Topic; Ferritins; Hodgkin Disease; Humans; Immunoglobulins; Indium Radioisotopes; Iodine Radioisotopes; Radioimmunotherapy; Yttrium Radioisotopes	1995
Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease. Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:5 Topics: Antibodies, Monoclonal; Dose Fractionation, Radiation; Ferritins; Hodgkin Disease; Humans; Immunoconjugates; Immunoglobulin G; Immunoglobulins; Indium Radioisotopes; Neoplasm Proteins; Yttrium Radioisotopes	2000

Trials

5 trial(s) available for yttrium radioisotopes and Hodgkin Disease

Article	Year
Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody. Anti-cancer drugs, 2007, Volume: 18, Issue:6 Topics: Adult; Antibodies, Monoclonal; Cohort Studies; Female; Ferritins; Hodgkin Disease; Humans; Immunoconjugates; Male; Neoplasm Staging; Radioimmunotherapy; Recurrence; Treatment Outcome; Yttrium Radioisotopes	2007
Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9 Topics: Adolescent; Adult; Antibodies; Bone Marrow Transplantation; Combined Modality Therapy; Drug Resistance; Female; Ferritins; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Radioimmunotherapy; Remission Induction; Survival Rate; Transplantation, Autologous; Yttrium Radioisotopes	1995
Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6 Topics: Adolescent; Adult; Antibodies, Monoclonal; Combined Modality Therapy; Drug Evaluation; Female; Ferritins; Follow-Up Studies; Hematologic Diseases; Hodgkin Disease; Humans; Indium Radioisotopes; Male; Middle Aged; Radiotherapy Dosage; Survival Rate; Yttrium Radioisotopes	1991
Polyclonal 90Yttrium labeled antiferritin for refractory Hodgkin's disease. International journal of radiation oncology, biology, physics, 1989, Volume: 17, Issue:4 Topics: Adolescent; Adult; Blood Cell Count; Bone Marrow Transplantation; Combined Modality Therapy; Female; Ferritins; Follow-Up Studies; Half-Life; Hodgkin Disease; Humans; Male; Transplantation, Autologous; Yttrium Radioisotopes	1989
International Clinical Trials in Radiation Oncology. Isotopic immunotherapy: radiolabelled antibody. International journal of radiation oncology, biology, physics, 1988, Volume: 14 Suppl 1 Topics: Antibodies; Clinical Trials as Topic; Ferritins; Hodgkin Disease; Humans; International Cooperation; Iodine Radioisotopes; Neoplasms; Radioisotopes; Yttrium Radioisotopes	1988

Other Studies

13 other study(ies) available for yttrium radioisotopes and Hodgkin Disease

Article	Year
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood advances, 2021, 12-14, Volume: 5, Issue:23 Topics: Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Radioimmunotherapy; Tissue Distribution; Transplantation Conditioning; Tumor Microenvironment; Yttrium Radioisotopes	2021
Long-term follow-up of 2 patients treated with European journal of haematology, 2018, Volume: 101, Issue:3 Topics: Adult; Biopsy; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Lymphocytes; Male; Positron Emission Tomography Computed Tomography; Radioimmunotherapy; Recurrence; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes	2018
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 2015, Oct-20, Volume: 112, Issue:42 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Daclizumab; Female; Hodgkin Disease; Humans; Immunoglobulin G; Interleukin-2 Receptor alpha Subunit; Male; Middle Aged; Phosphorylation; Recurrence; Young Adult; Yttrium Radioisotopes	2015
Targeting the tumor niche to treat cancer. Proceedings of the National Academy of Sciences of the United States of America, 2015, Oct-20, Volume: 112, Issue:42 Topics: Antibodies, Monoclonal, Humanized; Female; Hodgkin Disease; Humans; Immunoglobulin G; Interleukin-2 Receptor alpha Subunit; Male; Yttrium Radioisotopes	2015
Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:6 Topics: Adult; Aged; Antibodies, Monoclonal; Female; Hodgkin Disease; Humans; Male; Radioimmunotherapy; Yttrium Radioisotopes	2009
Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma. Onkologie, 2008, Volume: 31, Issue:1-2 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Biopsy; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radioimmunotherapy; Retreatment; Rituximab; Treatment Outcome; Yttrium Radioisotopes	2008
Radiolabeling of antibodies for therapy and diagnosis. Methods in molecular biology (Clifton, N.J.), 1995, Volume: 51 Topics: Adult; Clinical Trials, Phase I as Topic; Halogens; Hodgkin Disease; Humans; Indicators and Reagents; Indium Radioisotopes; Isotope Labeling; Male; Quality Control; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Yttrium Radioisotopes	1995
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Ferritins; Hodgkin Disease; Humans; Male; Neoplasm Proteins; Prognosis; Radioimmunotherapy; Survival Rate; Yttrium Radioisotopes	1993
Proposal for translational analysis and development of clinical radiolabeled immunoglobulin therapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1996, Volume: 41, Issue:2 Topics: Animals; Clinical Protocols; Dogs; Hodgkin Disease; Humans; Immunoconjugates; Macaca mulatta; Mice; Mice, Nude; Rabbits; Radioimmunotherapy; Yttrium Radioisotopes	1996
Recurrence of Hodgkin's disease after indium-111 and yttrium-90 labeled antiferritin administration. Cancer, 1997, Dec-15, Volume: 80, Issue:12 Suppl Topics: Ferritins; Hodgkin Disease; Humans; Indium Radioisotopes; Radioimmunotherapy; Recurrence; Yttrium Radioisotopes	1997
Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:10 Suppl Topics: Adult; Animals; Antibodies; Female; Ferritins; Hodgkin Disease; Humans; Indium Radioisotopes; Male; Middle Aged; Quality Control; Rabbits; Radioimmunotherapy; Tissue Distribution; Yttrium Radioisotopes	1999
Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin's disease treated with 90yttrium-silicate. Lung cancer (Amsterdam, Netherlands), 2000, Volume: 27, Issue:3 Topics: Hodgkin Disease; Humans; Male; Mesothelioma; Middle Aged; Neoplasms, Radiation-Induced; Pleural Neoplasms; Survivors; Yttrium Radioisotopes	2000
Selection of reagents for human radioimmunotherapy. International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:1 Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Dogs; Female; Ferritins; Hodgkin Disease; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Mice; Mice, Nude; Radioimmunotherapy; Radiotherapy Dosage; Yttrium Radioisotopes	1992